IDXX
NASDAQ
US
IDEXX Laboratories, Inc. - Common Stock
$569,55
▲ +$4,89
(+0,87%)
Vol 734K
11
Skor Kualitas
ok
Pemeriksaan Mendalam
2/5
ok
Pendapatan ✓
Laba Bersih ✓
>IPO ✗
Kap. Pasar
$54.0B
P/E
52,6
ROE
67,8%
Margin
24,7%
D/E
62,76
Beta
1,67
52W
$356–$770
Konsensus Wall Street
22 analis · Apr 20267
Beli Kuat
9
Beli
6
Tahan
0
Jual
0
Jual Kuat
72,7%
Peringkat Beli
Grafik Harga
Saham Serupa
Pendapatan
Tingkat beat: 100,0%| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Des 2025 | $2,99 | $3,08 | +$0,09 |
| Sep 2025 | $3,19 | $3,40 | +$0,21 |
| Jun 2025 | $3,37 | $3,63 | +$0,26 |
| Mar 2025 | $2,91 | $2,96 | +$0,05 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Pendapatan | $954.3M | $998.4M | $1.1B | $1.1B | $1.1B |
| Laba Bersih | $216.1M | $242.7M | $294.0M | $274.6M | $248.2M |
Tren Fundamental
| Metrik | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 64.4% | 64.4% | 64.4% | 64.4% | 67.8% | 67.8% |
| P/E (TTM) | 43.76 | 51.66 | 48.97 | 51.10 | 57.24 | 52.58 |
| Net Margin | 26.5% | 24.4% | 24.4% | 24.4% | 24.6% | 24.6% |
| Gross Margin | 62.6% | 61.5% | 61.5% | 61.5% | 61.7% | 61.7% |
| D/E Ratio | 75.66 | 75.66 | 75.66 | 75.66 | 62.76 | 62.76 |
| Current Ratio | 1.11 | 1.11 | 1.11 | 1.11 | 1.18 | 1.18 |
Rasio Utama
ROA (TTM)
31,1%
P/S (TTM)
12,96
P/B
21,2
EPS (TTM)
$12,61
CF/Share
$11,16
Pertumbuhan Pendapatan 3T
+6,6%
52W High
$769,98
52W Low
$356,14
$356,14
Rentang 52 Minggu
$769,98
Kesehatan Keuangan
Arus Kas Bebas
$326.1M
Utang Bersih
$796.0M
Kas
$180.1M
Total Utang
$976.1M
Per tanggal Des 31, 2025
Як IDXX виглядає на тлі конкурентів у Health Care?
Група порівняння: Micro-cap Health Care (All) · 241 компаній
Оцінка IDXX vs аналоги Health Care
P/E
52,6
▲
71%
di atas
rekan
(30,7)
vs Rekan
vs Industri
Undervalued
P/S
13,0
▲
402%
di atas
rekan
(2,6)
vs Rekan
vs Industri
Overvalued
P/B
21,2
▲
663%
di atas
rekan
(2,8)
vs Rekan
vs Industri
Overvalued
Дивідендна дохідність
—
▼
0%
di bawah
rekan
(0,7%)
vs Rekan
vs Industri
Yield rendah
Прибутковість IDXX vs аналоги Health Care
ROE
67,8%
▲
276%
di atas
rekan
(-38,5%)
vs Rekan
vs Industri
Tingkat atas
Net margin
24,7%
▲
200%
di atas
rekan
(-24,7%)
vs Rekan
vs Industri
Tingkat atas
Валова маржа
61,7%
▲
17%
di atas
rekan
(52,9%)
vs Rekan
vs Industri
Di bawah rata-rata
ROA
31,1%
▲
246%
di atas
rekan
(-21,2%)
vs Rekan
vs Industri
Tingkat atas
Фінансове здоровʼя IDXX vs аналоги Health Care
D/E ratio
62,8
▲
226%
di atas
rekan
(19,3)
vs Rekan
vs Industri
Utang tinggi
Поточна ліквідність
1,2
▼
45%
di bawah
rekan
(2,2)
vs Rekan
vs Industri
Likuiditas rendah
Beta
1,7
▲
59%
di atas
rekan
(1,1)
vs Rekan
vs Industri
Lebih volatil
Радар фундаменталів IDXX
IDXX
Median rekan
Industri
IDXX прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
IDXX vs аналоги: ключові метрики
Opini AI Terbaru
Grok
SKIP
Price action shows a prolonged downtrend from peaks above $750 in late 2025 to current levels around $558, with recent weekly closes declining from $636 (Mar 2) to $557 (Mar 30), indicating no clear reversal or upward momentum yet, making …
Apr 01, 2026